Izzar Rachid's Form 4 filing
Biogen Inc. (BIIB) · filed Jul 16, 2025
- Accession no.
- 0001127602-25-019295
- Filed
- Jul 16, 2025
- Trade date
- Jul 8, 2025
- Filing delay
- 8 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $300.1K. It was filed 8 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Izzar RachidCIK 0001875506 | Officer (Head of Global Product Strat.) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 8, 2025 | Common Stock | SSaleDisposed | −2,223 | $135.00 | −$300,105 | 6,330 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.